Gram Positive Agents Flashcards

1
Q

glycopeptides

A

vancomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

streptogramins

A

quinupristin:dalfopristin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

oxazolidinones

A

linezolid
tedezolid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

lipopeptides

A

daptomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

lipoglycopeptides

A

telavancin
oritavancin
dalbovancin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

vancomycin MOA

A

inhibits 2nd stage of cell wall synthesis by binding to the D-Ala-D-Ala cell wall precursors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

vancomycin cidal or static, time or conc dependent

A

bactericidal, slow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

mechanism of resistance vancomycin

A

modification of the D-Ala-D-Ala vancomycin binding site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

spectrum of activity vancomycin

A

gram positives
anaerobes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

target organisms vancomycin

A

PRSP
MSSA
MRSA
C. diff (po only)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

which is drug of choice for MRSA

A

vancomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

when should we measure serum

A

1 hour after end of infusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

does vanc penetrate CSF

A

no

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how is vanc eliminated? dose adjust?

A

excreted by kidney, requires dose adjustments based on CrCl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

which gram positive agent can be used for c. diff?

A

vancomycin orally

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

adverse events of vancomycin

A

red man syndrome
neohrotoxicity, ototoxicity
interstitial phlebitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

risk factors for nephro and ototoxicity

A

high doses
prolonged therapy
use of other agents causing nephro or ototox like chemo or pressors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

how does red man syndrome happen

A

related to rate of infusion, happens if given fast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

if red man syndrome happens, can you give vancomycin again

A

can give it again but prolong the infusion or give pretreatment with antihistamines or corticosteroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

mechanism of action quinupristin/dalfopristin

A

inhibits protein synthesis by binding to 50S ribosomal subunits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

quinupristin:dalfopristan cidal or static, conc or time dependent

A

static, time dependent

22
Q

linezolid, tedizolid MOA

A

inhibits protein synthesis by binding to the 50S ribosomal subunit near 30S interface

23
Q

linezolid, tedizolid static or cidal, time or conc

A

static
time dependent (linezolid)
conc dependent (tedizolid)

24
Q

mechanism of action daptomycin

A

causes membrane depolarization by inserting lipophillic tail in cell wall to form transmembrane channel, inhibits DNA synthesis

25
daptomycin, cidal or static, time or conc dependent
cidal concentration dependent
26
telavancin, oritavancin, dalbavancin MOA
inhibits cell wall synthesis by binding to D-Ala-D-Ala cell wall precursors AND causes cell membrane depolarization by inserting lipophilic tail in cell wall
27
telavancin, oritavancin, dalbavacin cidal or static, time or con
cidal concentration dependent
28
Synercid mechanism of resistance
alteration in ribosomal binding site, enzymatic inactivation
29
linezolid, tedizolid mechanism of resistance
alteration in ribosomal binding site (rare)
30
daptomycin mechanism of resistance
rarely reported, altered cell wall membrane binding through loss of membrane protein
31
telavancin, oritavancin, dalbovancin mechanism of resistance
modification of the D-Ala-D-Ala vancomycin binding site
32
spectrum of activity Synercid (quinupristin, dalfopristin)
gram positives only anaerobes
33
spectrum of activity linezolid, tedizolid
gram positive only anaerobes
34
spectrum of activity daptomycin
gram positives only anaerobes
35
spectrum of activity telavancin, oritavancin, dalbovancin
gram positives only anaerobes
36
target organisms for gram positive agents
PRSP MRSA MSSA VRE (except quinupristin: dalfopristin)
37
gram positive agents covering VISA and VRSA
linezolid, tidezolid daptomycin telavancin, oritavancin, dalbovancin
38
which gram positve agents have CSF penetration?
linezolid
39
which gram positives require renal dose adjustments
daptomycin telavancin dalbavancin
40
which gram positive requires hepatic dose adjustments
Synercid
41
side effects of Synercid (quinupristin, dalfopristin)
phlebitis myalgias arthralgias
42
linezolid side effects
optic and peripheral neuropathy thrombocytopenia, anemia
43
daptomycin side effects
myopathy and CPK elevation acute eosinophillic pneumonia
44
telavancin, oritavancin, dalbovancin side effects
nephrotoxicity QT prolongation taste werd infusion site reactions
45
which drug has risk of serotonin syndrome?
linezolid
46
which drug has interaction with HmgCoa reductase?
daptomycin, hold the statin
47
which drug has CYP3a4 interaction
Synercid
48
what drugs should you avoid with Synercid
3A4s cyclosporine statins tacrolimus carbamezepine
49
which drug interacts with aPTT tests
oritavancin, dalbovancin, telavancin
50
which gram positive should we avoid in pregnancy
dalbavancin, oritavancin, telavancin
51
which drugs preferred for VRE
linezolid daptomycin
52